Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Tang, Y; Blomenkamp, KS; Fickert, P; Trauner, M; Teckman, JH.
NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
PLoS One. 2018; 13(8):e0200897-e0200897
Doi: 10.1371/journal.pone.0200897
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Fickert Peter
-
Trauner Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Alpha-1 Antitrypsin (α1AT) Deficiency is a genetic disease in which accumulation of α1AT mutant Z (α1ATZ) protein in the ER of hepatocytes causes chronic liver injury, liver fibrosis, and hepatocellular carcinoma. No effective medical therapy is currently available for the disease. We previously found that norUDCA improves the α1AT deficiency associated liver disease by promoting autophagic degradation of α1ATZ protein in liver in a mouse model of the disease. The current study unravels the novel underlying cellular mechanism by which norUDCA modulates autophagy. HTOZ cells, modified from HeLa Tet-Off cells by transfection with the resulting pTRE1-ATZ plasmid and expressing mutant Z proteins, were studied in these experiments. The role of norUDCA in inducing autophagy, autophagy-mediated degradation of α1ATZ and the role of AMPK in norUDCA-induced autophagy were examined in the current report. NorUDCA promoted disposal of α1ATZ via autophagy-mediated degradation of α1ATZ in HTOZ cells. Activation of AMPK was required for norUDCA-induced autophagy and α1ATZ degradation. Moreover, mTOR/ULK1 was involved in norUDCA-induced AMPK activation and autophagy in HTOZ cells. Our results provide novel mechanistic insights into the therapeutic action of norUDCA in promoting the clearance of α1ATZ in vitro and suggest a novel therapeutic approach for the treatment of α1ATZ deficiency disease and its associated liver diseases.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenylate Kinase - metabolism
-
Animals -
-
Autophagy - drug effects
-
Autophagy-Related Protein-1 Homolog - metabolism
-
Disease Models, Animal -
-
HeLa Cells -
-
Humans -
-
Intracellular Signaling Peptides and Proteins - metabolism
-
Liver - drug effects
-
Liver - metabolism
-
Liver Diseases - drug therapy
-
Liver Diseases - metabolism
-
Mice -
-
Mutant Proteins - metabolism
-
Proteolysis -
-
RNA, Messenger - metabolism
-
Signal Transduction -
-
TOR Serine-Threonine Kinases - metabolism
-
Ursodeoxycholic Acid - analogs & derivatives
-
Ursodeoxycholic Acid - metabolism
-
Ursodeoxycholic Acid - pharmacology
-
alpha 1-Antitrypsin - metabolism